These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
11. Clinical significance of azathioprine active metabolite concentrations in inflammatory bowel disease. Wright S; Sanders DS; Lobo AJ; Lennard L Gut; 2004 Aug; 53(8):1123-8. PubMed ID: 15247179 [TBL] [Abstract][Full Text] [Related]
12. Therapeutic drug monitoring of azathioprine and 6-mercaptopurine metabolites in Crohn disease. Belaiche J; Desager JP; Horsmans Y; Louis E Scand J Gastroenterol; 2001 Jan; 36(1):71-6. PubMed ID: 11218242 [TBL] [Abstract][Full Text] [Related]
13. 5-aminosalicylate therapy is associated with higher 6-thioguanine levels in adults and children with inflammatory bowel disease in remission on 6-mercaptopurine or azathioprine. Hande S; Wilson-Rich N; Bousvaros A; Zholudev A; Maurer R; Banks P; Makrauer F; Reddy S; Burakoff R; Friedman S Inflamm Bowel Dis; 2006 Apr; 12(4):251-7. PubMed ID: 16633046 [TBL] [Abstract][Full Text] [Related]
14. 6-Thioguanine seems promising in azathioprine- or 6-mercaptopurine-intolerant inflammatory bowel disease patients: a short-term safety assessment. Derijks LJ; de Jong DJ; Gilissen LP; Engels LG; Hooymans PM; Jansen JB; Mulder CJ Eur J Gastroenterol Hepatol; 2003 Jan; 15(1):63-7. PubMed ID: 12544696 [TBL] [Abstract][Full Text] [Related]
15. A 6-thioguanine nucleotide threshold level of 400 pmol/8 x 10(8) erythrocytes predicts azathioprine refractoriness in patients with inflammatory bowel disease and normal TPMT activity. Roblin X; Peyrin-Biroulet L; Phelip JM; Nancey S; Flourie B Am J Gastroenterol; 2008 Dec; 103(12):3115-22. PubMed ID: 19086961 [TBL] [Abstract][Full Text] [Related]
16. The pharmacokinetic effect of adalimumab on thiopurine metabolism in Crohn's disease patients. Wong DR; Pierik M; Seinen ML; van Bodegraven AA; Gilissen LP; Bus P; Bakker JA; Masclee AA; Neef C; Engels LG; Hooymans PM J Crohns Colitis; 2014 Feb; 8(2):120-8. PubMed ID: 23932783 [TBL] [Abstract][Full Text] [Related]
17. Multicentric Case-Control Study on Azathioprine Dose and Pharmacokinetics in Early-onset Pediatric Inflammatory Bowel Disease. Stocco G; Martelossi S; Arrigo S; Barabino A; Aloi M; Martinelli M; Miele E; Knafelz D; Romano C; Naviglio S; Favretto D; Cuzzoni E; Franca R; Decorti G; Ventura A Inflamm Bowel Dis; 2017 Apr; 23(4):628-634. PubMed ID: 28296824 [TBL] [Abstract][Full Text] [Related]
18. Lack of effect of intravenous administration on time to respond to azathioprine for steroid-treated Crohn's disease. North American Azathioprine Study Group. Sandborn WJ; Tremaine WJ; Wolf DC; Targan SR; Sninsky CA; Sutherland LR; Hanauer SB; McDonald JW; Feagan BG; Fedorak RN; Isaacs KL; Pike MG; Mays DC; Lipsky JJ; Gordon S; Kleoudis CS; Murdock RH Gastroenterology; 1999 Sep; 117(3):527-35. PubMed ID: 10464128 [TBL] [Abstract][Full Text] [Related]
19. Determination of Concentrations of Azathioprine Metabolites 6-Thioguanine and 6-Methylmercaptopurine in Whole Blood With the Use of Liquid Chromatography Combined With Mass Spectrometry. Zochowska D; Zegarska J; Hryniewiecka E; Samborowska E; Jazwiec R; Tszyrsznic W; Borowiec A; Dadlez M; Paczek L Transplant Proc; 2016 Jun; 48(5):1836-9. PubMed ID: 27496503 [TBL] [Abstract][Full Text] [Related]
20. Therapeutic drug monitoring of thiopurine metabolites in adult thiopurine tolerant IBD patients on maintenance therapy. Gilissen LP; Wong DR; Engels LG; Bierau J; Bakker JA; Paulussen AD; Romberg-Camps MJ; Stronkhorst A; Bus P; Bos LP; Hooymans PM; Stockbrügger RW; Neef C; Masclee AA J Crohns Colitis; 2012 Jul; 6(6):698-707. PubMed ID: 22398098 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]